| Co-Investigator(Kenkyū-buntansha) |
稲澤 譲治 東京医科歯科大学, 難治疾患研究所, 教授 (30193551)
高橋 隆 愛知県がんセンター(研究所), 総長, 総長 (50231395)
武藤 香織 東京大学, 医科学研究所, 教授 (50345766)
小川 誠司 京都大学, 医学研究科, 教授 (60292900)
岡田 随象 大阪大学, 医学系研究科, 教授 (70727411)
|
|---|
| Budget Amount *help |
¥42,120,000 (Direct Cost: ¥32,400,000、Indirect Cost: ¥9,720,000)
Fiscal Year 2019: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)
Fiscal Year 2018: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)
Fiscal Year 2017: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)
Fiscal Year 2016: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)
Fiscal Year 2015: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
|
|---|
| Outline of Final Research Achievements |
The area of "systems cancer," which combines cancer biology and cancer research with computational system biology, is deepened by utilizing supercomputers and artificial intelligence, and at the same time, is a patient-centered principle that responds to innovations in genome analysis. By fusing ELSI research, we managed to create a new dimension of cancer research fusion area. We published a series of newsletters and held symposia. In addition, a series of seminars on large-scale data analysis and analysis technology using supercomputers was held.
|
